INTRODUCTION 16
Phosphoribosyl amine (PRA) participates in cellular metabolism as an intermediate required for 17 both purine and thiamine production (11, 21, 22) , and is synthesized by the first enzyme in the 18 purine biosynthetic pathway (PurF) (19, 21) . In Salmonella enterica, the activity of PurF can be 19 bypassed in thiamine (but not purine) synthesis, indicating the existence of alternative pathways 20 generating at least small amounts of PRA (10, 24). We have hypothesized that PRA synthesis in 21 the absence of PurF is the result of promiscuous enzymes involved in different metabolic 22 processes. This hypothesis was supported by the demonstration that in at least two situations the 23 anthranilate synthase-phosphoribosyltransferase (AS-PRT) complex is required for PRA 1 formation in vivo (4, 27) . The AS-PRT complex is a multi-functional enzyme (chorismate 2 pyruvate-lyase, EC 4.1.3.27 and N-(5'-phosphoribosyl)-anthranilate pyrophosphate 3 phosphoribosyltransferase, EC 2.4.2.18) that catalyzes the first and second steps of tryptophan 4 biosynthesis (2, 34) (Fig. 1A) . The products of the trpE and trpD genes, the first two in the 5 tryptophan operon, compose this allosteric heterotetrameric (TrpE 2 -TrpD 2 ) enzyme, which has 6 been extensively studied (2, 34) . The AS-PRT complex catalyzes both the formation of 7
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anthranilate from chorismate and L-glutamine (2, 14) and the formation of N-(5'-8 phosphoribosyl)-anthranilate from anthranilate and 5-phosphoribose-1-pyrophosphate (PRPP) 9
( Fig. 1A) (2, 13) . Phosphoribosyl transfer requires the carboxy-terminal domain of the TrpD 10 subunit (12) and the ability of the TrpD subunit to perform this reaction is equivalent to that of 11 the complex (TrpE2-TrpD2) (2, 13) . Each of the enzymatic activities is negatively feedback-12 regulated by tryptophan at a well-defined allosteric binding site (20, 34, 35) . 13
The step in the biosynthetic pathway for tryptophan following the action of AS-PRT is 14 catalyzed by the product of trpC, N-(5'-phosphoribosyl)anthranilate isomerase, EC 5.3.1.24 (PR-15 AnI); indole-3-glycerol-phosphate synthase, EC 4.1.
(IGPS). TrpC is a monomeric 16
bifunctional enzyme (18). The two catalytic activities of this enzyme are located on different 17 domains of the protein and act sequentially in the biosynthetic pathway (Fig. 1B) . While the N-18
terminal domain contains the IGPS activity, the C-terminal domain catalyzes the isomerization 19 of PR-anthranilate to 1-(o-carboxyphenylamino)-1-deoxyribulose 5-phosphate (CdRP) (15, 33), 20 which is the first of the two reactions metabolically. Both domains consist of a parallel β-barrel 21 core of eight strands that form a pocket where the active site is located, and eight surrounding α-22 helices (26) . 23 Genetic methods. Transduction methods. Transductional crosses were performed using the 1 high-frequency general transducing mutant of bacteriophage P22 (HT105/1, int-201) (28) as has 2 been described previously (9) . Transductants were purified by colony isolation on nonselective 3 green indicator plates (6), and verified to be phage-free by cross-streaking with phage P22. Solid media. Nutritional requirements were measured by growing the strains on rich agar 1 medium and replica plating to minimal agar medium containing the appropriate nutrients. 2
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Growth was assessed after 24 h incubation at 37 o C. Cross-feeding was measured by spotting 3 relevant samples (cells or supernatants) on a soft agar overlay seeded with a strain containing 4 trpE8 (old designation trpA8 (3), kindly provided by J. Roth). 5
Plasmid constructs. Genomic DNA of strain DM6418 (purF2085 gnd-181 zdd-6 9147::Tn10d(Tc)) was purified from bacterial cells using an Easy-DNA kit (Invitrogen Life 7
Technologies; Carlsbad, CA). Cloned Pfu DNA polymerase from Pyroccoccus furiosus 8 (Stratagene; La Jolla, Calif.) was used in PCR reactions. The PCR fragment corresponding to the 9 trpD (1610 bp) gene was gel-purified, digested with the appropriate restriction enzymes and 10 cloned into the expression vector pET-28a (Novagen, Darmstadt, Germany). The ligation mix 11 was transformed into Escherichia coli strain DH5α, and DNA sequencing (University of 12
Wisconsin Biotechnology Center-Nucleic Acid and Protein Facility) was used to verify the 13 plasmid constructs. 14 Purification of TrpD enzyme. An expression vector containing the trpD gene under control of T 7 15 promoter (pET-trpD) was freshly transformed into Escherichia coli BL21. Overnight cultures 16 were used to inoculate Luria-Bertani (LB) broth supplemented with 50 µg/ml kanamycin and the 17 cultures were grown to an optical density at 650nm of 0.6 at 37°C. The cells were cooled to 30°C 18 and then induced with 1.0 mM isopropyl-β-D-thiogalactopyranoside (IPTG). The cells were 19 grown for an additional 5 h at 30°C, harvested and resuspended in Binding buffer (5 mM 20 imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9). All subsequent purification steps were 21 performed at 4°C. Cells were disrupted using a French pressure cell at 10 4 kPa, followed by brief 22 sonication using a Sonic Dismembrator 550 (Fisher Scientific). Clarified cell-free extract was 23 Anthranilate was detected by fluorescence at 325nm excitation and 400nm emission 14

wavelengths. 15
Phosphoribosylamine-forming activity was determined using a modified assay initially described 16 for PurF (17, 29). Synthesis of PRA from PRPP and ammonium was determined as a function of 17 [1- 14 C]-glycinamide ribonucleotide (GAR) produced in a coupled reaction catalyzed by GAR 18 synthetase (PurD) enzyme (Fig. 2B) . A molecule of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-glycine is condensed with PRA to 19 yield GAR. The reactions were performed in 50 mM potassium phosphate buffer pH 8.0 in the 20 presence of 10 mM PRPP, 10 mM MgCl 2 , 2.5 mM ATP, 25 mM 14 C-glycine (26 nCi), 10 mM 21 NH 4 Cl, 2 µg of GAR synthetase. PurD was overexpressed and purified as previously described 22 (27). In a standard assay, reactions were started by the addition of 5-10 µg of purified TrpD and 23 
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RESULTS 1
TrpD-mediated PRA generation in vitro requires anthranilate. Previous genetic results 2 suggested that purified TrpD would mediate PRA formation from PRPP and NH 3 . TrpD 3 containing an N-terminal His-Tag fusion was purified to >95% purity and assayed for inherent 4 phosphoribosyl transferase activity. A typical preparation converted 1.9 µmoles of anthranilate 5 to phosphoribosyl anthranilate per min when both anthranilate and PRPP were provided in the 6 assay mix. Potential formation of PRA was assessed utilizing PurD in a coupled assay, when 7 PRPP, NH 3 and TrpD were provided in the assay mixture. Under the conditions tested, PRA 8 formation was detected only when anthranilate was also added to the reaction ( (Fig. 4) . 3
The products of PR-anthranilate breakdown are anthranilate and R5P (30), suggesting 4 that PRA might be generated by a non-enzymatic reaction between accumulating R5P and the 5 ammonia present in the reaction mix. Non-enzymatic formation of PRA has been well 6 characterized (23), and its potential contribution was determined by performing the coupled 7 assay in two steps. PR-anthranilate was formed by TrpD from anthranilate and PRPP. 8
Conversion of anthranilate to PR-anthranilate was judged to be complete when fluorescence in 9 the mixture decreased to that of the blank. Proteins in the assay mix were then removed by ultra 10 filtration with a 3 kDa cut off membrane, and the resulting eluant was provided as a source of 11 R5P to a reaction mixture containing NH 3 and the components for 14 C-GAR synthesis. Data from 12 this experiment, shown in Table 2 , indicated that when PurD was the only enzyme in the assay 13 mixture the eluant allowed GAR formation. These data allowed the conclusion that non-14 enzymatic PRA formation was occurring between R5P and NH 3 . Taken together the above 15 results suggested that anthranilate was being recycled by TrpD to synthesize more PR-16 anthranilate, which resulted in the continuous formation of R5P allowing non-enzymatic 17 formation of PRA as depicted in Fig. 5 . accumulation of R5P endogenously. A purF gnd trpC::Tn10 mutant strain was generated to 1 determine if the process described in vitro could be forced to occur in vivo by manipulating 2 metabolic flux. Two regulatory mutations were incorporated into the strain to ensure that 3 metabolic flux reached the genetically blocked step in the presence of the required tryptophan. 4 An insertion in trpR relieved repression (4, 25) and an allosterically insensitive variant of TrpE 5 (trpE3613) prevented feedback inhibition (4, 5). The strain lacking trpC and defective in 6 regulation by tryptophan showed significant growth in the absence of thiamine as shown in Fig.  7 6. This result was consistent with the hypothesis that the limiting metabolite for non-enzymatic 8 PRA formation in vivo is R5P. 9
10
Disruption of flux through the tryptophan biosynthetic pathway can increase PRA formation in 11
vivo. The experiment above employed a contrived strain that was lacking a major biosynthetic 12 enzyme and as such the value of this result in conclusions about a physiological role for non-13 enzymatically generated PRA was limited. Mutations that restored PurF-independent PRA 14 synthesis, mapped to the tryptophan operon, and allowed retention of the ability to grow in the 15 absence of tryptophan were sought using localized mutagenesis. A phage lysate grown on a DES 16 mutagenized strain (DM1) was used to transduce strain DM6806 (purF2085 gnd-181 17 trpC::Tn10d(Tc)) to Trp + on medium containing adenine and thiamine. Trp + transductants were 18 replica-printed to minimal medium supplemented with adenine, and growth was scored. Seven 19 Trp + Thi + mutants were isolated. Genetic reconstruction determined the causative mutation in 6 20 of the 7 strains was 100% linked to the tryptophan operon, and these mutations were further 21 characterized. 22 Together these results indicated that growth of these strains in the absence of thiamine was a 3 result of PRA production by a tryptophan-regulated mechanism. 4 trpC mutants excrete anthranilate. The phenotypic similarities between the strains carrying trpC 5 point mutations and a strain lacking trpC, in addition to their location in the coding sequence, 6 suggested these alleles had compromised the isomerase activity. Given the prototrophic nature of 7 the relevant strains, the indirect aspect of available assays, and potential complexities of the 8 metabolic network involved, the predicted accumulation of anthranilate was tested by bioassay. allows an organism to compensate for defects in one metabolic branch by altering another. The 1 studies described here were initiated to test the prediction that the AS-PRT (TrpDE) enzyme 2 complex could generate phosphoribosyl amine (PRA) (27). However, data from the in vitro 3 studies unexpectedly led to the conclusion that PRA needed for thiamine synthesis could be 4 generated non-enzymatically if carbon flux through the tryptophan biosynthetic pathway was 5 altered. 6
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The in vitro system described herein serendipitously allowed the generation (and 7 detection) of PRA that was formed non-enzymatically from ribose-5-P and NH 3 . Manipulation 8 of the assay system allowed the conclusion that the TrpD enzyme mediated the conversion of 9 PRPP to R5P through a PR-anthranilate intermediate (Fig. 6) . Thus in this isolated system, the 10 critical product of the TrpD reaction was R5P, generated by breakdown of the unstable PR-11
anthranilate. The R5P then condensed with NH 3 present to generate PRA. It is important to note 12 that these results did not address the possibility that TrpD can enzymatically generate PRA under 13 some condition(s). 14 The instability of PR-Anthranilate has been previously described (7). However, a role for 15 the breakdown products in metabolism had not been considered since the subsequent enzyme in 16 the pathway (TrpC) would be expected to remove this metabolite before breakdown. physiological potential for non-enzymatic PRA formation. Cross-feeding studies detected the 1 expected excretion of anthranilate, making all data consistent with accumulation of PR-2 anthranilate being indirectly responsible for thiamine synthesis in these strains. These data allow 3 the conclusion that R5P is the limiting metabolite for non-enzymatic formation of PRA in vivo, 4 at least in the medium used. This conclusion explains why no mutations have been isolated that 5 prevent PurF-independent thiamine synthesis when cells are grown on ribose. Use of ribose as a 6 sole carbon source would be expected to elevate R5P levels. 7
Five of the trpC mutations restoring PRA synthesis affected residues in the PR-AnI 8 domain and one mutation affected the single amino acid that serves as a bridge between the two 9 domains. The diversity of mutations that resulted in a similar phenotype by distinctly altering the 10 TrpC enzyme, yet failing to compromise tryptophan independent growth was unexpected. The 11 presence of one mutation that generated a termination codon was noteworthy since activity 12 sufficient for tryptophan biosynthesis was maintained. It seems likely that low levels of read-13 through of the UAG codon produced enough functional TrpC to allow synthesis of tryptophan. It 14 was telling that each of the randomly generated mutations that survived the selection mapped to 15 the isomerase domain of the protein. This activity is the first of the two sequential reactions the 16 enzyme catalyzes in tryptophan biosynthesis and significantly is the one that acts on PR-17
anthranilate. This result emphasized the need for the specific accumulation of PR-anthranilate. 18
In a global context, this work illustrates several points. This work suggests that even in highly conserved proteins, key residues involved in catalysis are 2 not the only critical feature to be maintained. Finally, this work demonstrates that changes in a 3 protein can alter metabolic flux in a way that has a global impact on metabolism, yet can not be 4 predicted, or in fact measured if only one output is monitored. As such, protein variants should 5 be considered to be optimized for function in the native metabolic network. If this view is 6 correct, it has implications for evaluating essential residues and protein evolution in the context 7 of a single activity, or pathway. Rather, analysis of the relevant network, and its conservation in 8 different organisms may provide a better understanding of the forces at work to constrain and 9 define metabolism and allow for the critical inherent robustness. PurD and 14C-glycine, and GAR formed was monitored by phosphorimage analyses. 13 a numbers represent phosphorimager units representing the amount of GAR formed. 14 Step #1
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